Correlation between serum levels of proprotein convertase subtilisin/kexin type 9 (PCSK9) and atherogenic lipoproteins in patients with coronary artery disease
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1476-511X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Correlation between serum levels of proprotein convertase subtilisin/kexin type 9 (PCSK9) and atherogenic lipoproteins in patients with coronary artery disease ; volume:15 ; number:1 ; day:22 ; month:9 ; year:2016 ; pages:1-7 ; date:12.2016
Lipids in health and disease ; 15, Heft 1 (22.9.2016), 1-7, 12.2016
- Creator
-
Nozue, Tsuyoshi
- Contributor
-
Hattori, Hiroaki
Ogawa, Kazuyuki
Kujiraoka, Takeshi
Iwasaki, Tadao
Hirano, Tsutomu
Michishita, Ichiro
SpringerLink (Online service)
- DOI
-
10.1186/s12944-016-0339-8
- URN
-
urn:nbn:de:1111-2016102311137
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:45 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Nozue, Tsuyoshi
- Hattori, Hiroaki
- Ogawa, Kazuyuki
- Kujiraoka, Takeshi
- Iwasaki, Tadao
- Hirano, Tsutomu
- Michishita, Ichiro
- SpringerLink (Online service)
Other Objects (12)
Mediating role of atherogenic lipoproteins in the relationship between liver fat and coronary artery calcification
Relation of atherogenic lipoproteins with estimated glomerular filtration rate decline: a longitudinal study
Comparative Analysis of Atherogenic Lipoproteins L5 and Lp(a) in Atherosclerotic Cardiovascular Disease
Quantifying atherogenic lipoproteins for lipid-lowering strategies: consensus-based recommendations from EAS and EFLM
Correlation between atherogenic index of plasma and coronary artery disease in males of different ages: a retrospective study
PCSK9 and Coronary Artery Plaque—New Opportunity or Red Herring?
Plasma atherogenic indices are independent predictors of slow coronary flow
ApoA-I/A-II-HDL positively associates with apoB-lipoproteins as a potential atherogenic indicator
Atherogenic subfractions of lipoproteins in the treatment of metabolic syndrome by physical activity and diet – the RESOLVE trial
Atherogenic index of plasma and coronary artery disease: A systematic review
The elevation of plasma concentrations of apoB-48-containing lipoproteins in familial hypercholesterolemia is independent of PCSK9 levels
Human plasma lipoproteins
Mediating role of atherogenic lipoproteins in the relationship between liver fat and coronary artery calcification
Relation of atherogenic lipoproteins with estimated glomerular filtration rate decline: a longitudinal study
Comparative Analysis of Atherogenic Lipoproteins L5 and Lp(a) in Atherosclerotic Cardiovascular Disease
Quantifying atherogenic lipoproteins for lipid-lowering strategies: consensus-based recommendations from EAS and EFLM
Correlation between atherogenic index of plasma and coronary artery disease in males of different ages: a retrospective study
PCSK9 and Coronary Artery Plaque—New Opportunity or Red Herring?
Plasma atherogenic indices are independent predictors of slow coronary flow
ApoA-I/A-II-HDL positively associates with apoB-lipoproteins as a potential atherogenic indicator
Atherogenic subfractions of lipoproteins in the treatment of metabolic syndrome by physical activity and diet – the RESOLVE trial
Atherogenic index of plasma and coronary artery disease: A systematic review
The elevation of plasma concentrations of apoB-48-containing lipoproteins in familial hypercholesterolemia is independent of PCSK9 levels
Human plasma lipoproteins
Mediating role of atherogenic lipoproteins in the relationship between liver fat and coronary artery calcification
Relation of atherogenic lipoproteins with estimated glomerular filtration rate decline: a longitudinal study
Comparative Analysis of Atherogenic Lipoproteins L5 and Lp(a) in Atherosclerotic Cardiovascular Disease
Quantifying atherogenic lipoproteins for lipid-lowering strategies: consensus-based recommendations from EAS and EFLM
Correlation between atherogenic index of plasma and coronary artery disease in males of different ages: a retrospective study
PCSK9 and Coronary Artery Plaque—New Opportunity or Red Herring?
Plasma atherogenic indices are independent predictors of slow coronary flow
ApoA-I/A-II-HDL positively associates with apoB-lipoproteins as a potential atherogenic indicator
Atherogenic subfractions of lipoproteins in the treatment of metabolic syndrome by physical activity and diet – the RESOLVE trial
Atherogenic index of plasma and coronary artery disease: A systematic review
The elevation of plasma concentrations of apoB-48-containing lipoproteins in familial hypercholesterolemia is independent of PCSK9 levels